WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
+$10.4B
(-3.6%)
Cap. Flow
-$61.9M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
$123M |
| 2 |
Electronic Arts
EA
|
$102M |
| 3 |
Chord Energy
CHRD
|
$100M |
| 4 |
Quest Diagnostics
DGX
|
$89.2M |
| 5 |
Sensata Technologies
ST
|
$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
$138M |
| 2 |
Avnet
AVT
|
$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$73.5M |
| 5 |
Amazon
AMZN
|
$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $258M | 2.46% | 284,589 -33,235 | -10% | -$30.1M |
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $191M | 1.82% | 181,897 +11,295 | +7% | +$11.9M |
|
3
Ovintiv
OVV
$10.8B
| $190M | 1.81% | 4,053,740 +943,641 | +30% | +$44.2M |
|
4
TE Connectivity
TEL
$61B
| $161M | 1.54% | 1,071,487 -412,082 | -28% | -$62M |
|
5
AbbVie
ABBV
$372B
| $129M | 1.23% | 750,322 +111,929 | +18% | +$19.2M |
|
6
Revolution Medicines
RVMD
$7.1B
| $128M | 1.22% | 3,290,791 -506,357 | -13% | -$19.7M |
|
|
7
Chord Energy
CHRD
$6.29B
| $126M | 1.21% | 754,256 +598,070 | +383% | +$100M |
|
8
Meta Platforms (Facebook)
META
$1.86T
| $125M | 1.19% | 247,590 +2,081 | +0.8% | +$1.05M |
|
|
9
Marsh & McLennan
MMC
$101B
| $123M | 1.18% | +585,204 | New | +$123M |
|
10
Permian Resources
PR
$10B
| $113M | 1.07% | 6,969,331 +1,078,467 | +18% | +$17.4M |
|
|
11
Quest Diagnostics
DGX
$20.3B
| $107M | 1.02% | 783,903 +651,672 | +493% | +$89.2M |
|
12
Civitas Resources
CIVI
$3.41B
| $103M | 0.98% | 1,490,430 +1,045,583 | +235% | +$72.1M |
|
|
13
Electronic Arts
EA
$43B
| $102M | 0.98% | +735,372 | New | +$102M |
|
14
Progressive
PGR
$145B
| $100M | 0.96% | 483,739 +163,983 | +51% | +$34.1M |
|
15
Zimmer Biomet
ZBH
$21B
| $99.5M | 0.95% | 917,202 +1,852 | +0.2% | +$201K |
|
16
Arthur J. Gallagher & Co
AJG
$77.6B
| $97.8M | 0.93% | 377,269 +62,777 | +20% | +$16.3M |
|
|
BPMC
17
DELISTED
Blueprint Medicines
BPMC
| $94.9M | 0.91% | 880,147 +52,974 | +6% | +$5.71M |
|
18
Fortive
FTV
$16.2B
| $92.9M | 0.89% | 1,253,528 +751,301 | +150% | +$55.7M |
|
19
Amgen
AMGN
$155B
| $91.3M | 0.87% | 292,133 +139,980 | +92% | +$43.7M |
|
20
Merck
MRK
$210B
| $88.1M | 0.84% | 711,353 -264,664 | -27% | -$32.8M |
|
21
Keysight
KEYS
$28.1B
| $85.2M | 0.81% | 622,701 +99,833 | +19% | +$13.7M |
|
22
Roivant Sciences
ROIV
$8.15B
| $84.6M | 0.81% | 8,000,939 -3,171,367 | -28% | -$33.5M |
|
|
23
Sensata Technologies
ST
$4.74B
| $82.5M | 0.79% | 2,206,080 +1,974,532 | +853% | +$73.8M |
|
24
EQT Corp
EQT
$32.4B
| $81.2M | 0.78% | 2,196,436 +378,028 | +21% | +$14M |
|
25
Boston Scientific
BSX
$156B
| $79.4M | 0.76% | 1,031,633 +844,337 | +451% | +$65M |
|